Janux Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JANX and other ETFs, options, and stocks.About JANX
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
CEODavid Campbell
CEODavid Campbell
Employees81
Employees81
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2017
Founded2017
Employees81
Employees81
JANX Key Statistics
Market cap825.83M
Market cap825.83M
Price-Earnings ratio-8.19
Price-Earnings ratio-8.19
Dividend yield—
Dividend yield—
Average volume1.50M
Average volume1.50M
High today$14.27
High today$14.27
Low today$13.55
Low today$13.55
Open price$14.13
Open price$14.13
Volume1.47M
Volume1.47M
52 Week high$47.58
52 Week high$47.58
52 Week low$13.26
52 Week low$13.26
Stock Snapshot
The current Janux Therapeutics(JANX) stock price is $13.92, with a market capitalization of 825.83M. The stock trades at a price-to-earnings (P/E) ratio of -8.19.
On 2026-01-16, Janux Therapeutics(JANX) stock traded between a low of $13.55 and a high of $14.27. Shares are currently priced at $13.92, which is +2.7% above the low and -2.5% below the high.
Janux Therapeutics(JANX) shares are trading with a volume of 1.47M, against a daily average of 1.5M.
During the past year, Janux Therapeutics(JANX) stock moved between $13.26 at its lowest and $47.58 at its peak.
During the past year, Janux Therapeutics(JANX) stock moved between $13.26 at its lowest and $47.58 at its peak.
Analyst ratings
95%
of 20 ratingsBuy
95%
Hold
5%
Sell
0%
People also own
Based on the portfolios of people who own JANX. This list is generated using Robinhood data, and it’s not a recommendation.